The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 983.00
Bid: 980.00
Ask: 983.00
Change: 5.00 (0.51%)
Spread: 3.00 (0.306%)
Open: 997.00
High: 1,004.00
Low: 977.00
Prev. Close: 978.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

22 Jun 2023 07:00

RNS Number : 4804D
CVS Group plc
22 June 2023
 

For Immediate Release

22 June 2023

 

CVS Group plc("CVS", the "Company" or the "Group")

Appointments of non-executive director and Deputy CEO

CVS, the quoted provider of integrated veterinary services, is pleased to announce the appointment of Joanne Shaw as Non-executive Director with effect from 1 July 2023. 

 

Joanne Mary Shaw (59), has significant healthcare experience from her current roles as Trustee and Audit Committee Chair at Cancer Research UK, Chair at the Royal College of Paediatrics and Child Health, and Deputy Chair at Vitality UK. She has held a number of previous non-executive roles over the past 17 years including as non-executive director and Chair of the Audit and Risk Committee at NHS England and the National Audit Office, Chair of NHS Direct, Non-executive Director at Kensington and Chelsea Primary Care Trust and Chair of the British Equestrian Association. Joanne, who qualified as a chartered accountant, was a former management consultant at Boston Consulting Group and has previous executive roles at the Medicines Partnership, the Audit Commission and Coopers & Lybrand.

 

In her role of Non-executive Director, Joanne will become a member of the Audit, Remuneration and Nominations committees of the Board.

 

The Board is also pleased to announce the appointment of Ben Jacklin, Chief Operating Officer, to a newly created role of Deputy CEO, also with effect from 1 July 2023. Ben will retain responsibility for leading the Group's operations in the UK and internationally.

 

Chairman Richard Connell commented:

 

"On behalf of the Board I am delighted to welcome Joanne Shaw as a Non-executive Director. Her extensive healthcare experience will support the Board and the wider Group in delivering its purpose to provide the best possible care to animals. The Board looks forward to her input and to working together to deliver further success for the Group.

 

I am also delighted to congratulate Ben Jacklin on his promotion to Deputy CEO which is a reflection of Ben's significant contribution to the Group over the past few years."

 

 

Contacts:

 

CVS Group plc via Camarco

Richard Fairman, CEO

Ben Jacklin, COO

Robin Alfonso, CFO

 

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

 

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

Letaba Rimell +44 (0)7789 151 644

 

 

 

Additional Disclosures under the AIM Rules for Companies:

 

In relation to the appointment of Joanne Shaw, aged 59:

 

Current directorships/partnerships Past directorships/partnerships

Royal College of Paediatrics & Child Health NHS England

Cancer Research UK Nuffield Health

Cancer Research UK Trading Ltd Discovery Holdings Europe Ltd

Imperial Cancer Research Fund

Vitality Corporate Services Ltd

Vitality Health Ltd

Vanguard Metropolitan Ltd

 

At the date of this announcement Joanne Shaw does not hold any ordinary shares in the Company.

 

Save for the above, there are no further disclosures to be made in accordance with Rule 17 and 2 paragraph (g) of the AIM Rules for Companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUAVAROWUNUAR
Date   Source Headline
30th Nov 20184:53 pmRNSHolding(s) in Company
29th Nov 20181:48 pmRNSResult of AGM
29th Nov 20187:00 amRNSAnnual General Meeting Trading Update
14th Nov 201811:48 amRNSHolding(s) in Company
12th Nov 20183:56 pmRNSHolding(s) in Company
12th Nov 20183:50 pmRNSHolding(s) in Company
6th Nov 20185:11 pmRNSPosting of Annual Report and Notice of AGM
5th Nov 20188:05 amRNSExercise of Options, Directors' Dealing and TVR
31st Oct 20185:32 pmRNSTotal Voting Rights
24th Oct 201810:43 amRNSHolding(s) in Company
16th Oct 201812:51 pmRNSLong Term Incentive Plan Awards
15th Oct 20187:00 amRNSHolding(s) in Company
4th Oct 20187:00 amRNSExercise of Options and Total Voting Rights
27th Sep 20187:00 amRNSPreliminary Results
21st Sep 20184:21 pmRNSHolding(s) in Company
21st Sep 20184:21 pmRNSHolding(s) in Company
24th Aug 201812:22 pmRNSHolding(s) in Company
23rd Aug 20182:56 pmRNSHolding(s) in Company
21st Aug 20184:22 pmRNSHolding(s) in Company
21st Aug 20183:32 pmRNSHolding(s) in Company
2nd Aug 20187:00 amRNSTrading Statement & Board Update
31st Jul 20185:45 pmRNSExercise of Options and Total Voting Rights
20th Jul 20187:00 amRNSBoard Changes and Notice of Trading Update
10th Jul 201810:35 amRNSHolding(s) in Company
6th Jul 20185:11 pmRNSHolding(s) in Company
2nd Jul 20184:51 pmRNSDirector/PDMR Shareholding
2nd Jul 20184:46 pmRNSTotal Voting Rights
2nd Jul 20183:05 pmRNSHolding(s) in Company
19th Jun 20187:00 amRNSBlock listing Interim Review
7th Jun 20184:18 pmRNSHolding(s) in Company
31st May 20183:40 pmRNSExercise of Options and Total Voting Rights
22nd May 20182:47 pmRNSHolding(s) in Company
18th May 20184:33 pmRNSHolding(s) in Company
10th May 20182:33 pmRNSHolding(s) in Company
4th May 20185:31 pmRNSHolding(s) in Company
30th Apr 20184:47 pmRNSTotal Voting Rights
24th Apr 20183:13 pmRNSHolding(s) in Company
23rd Apr 20185:55 pmRNSHolding(s) in Company
10th Apr 20182:26 pmRNSExercise of Options & TVR
4th Apr 201812:05 pmRNSDirector/PDMR and PCA Shareholding
3rd Apr 20188:20 amRNSHolding(s) in Company
29th Mar 20187:00 amRNSTotal Voting Rights
28th Mar 20184:42 pmRNSExercise of Options, Director/PCA Dealing & TVR
20th Mar 20183:06 pmRNSExercise of Options, Directors' dealings and TVR
1st Mar 20183:30 pmRNSTotal Voting Rights
21st Feb 20184:17 pmRNSHolding(s) in Company
16th Feb 20185:36 pmRNSResult of Placing
16th Feb 201812:45 pmRNSPlacing Update
16th Feb 201811:05 amRNSClose of Accelerated Bookbuild
16th Feb 20187:01 amRNSProposed Accelerated Bookbuild

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.